EGFR and central nervous system cancer: For example, miR-7 and miR-221/222 have been shown to be involved in the activation of the Akt and epidermal growth factor receptor (EGFR) signaling pathways in gliomas [14], [15] while miR-34a was found to be a key regulator of p53 [16].